Lawrance IC, Welman CJ, Shipman P, Murray K. Correlation of MRI-determined small bowel Crohn’s disease categories with medical response and surgical pathology. World J Gastroenterol 2009; 15(27): 3367-3375 [PMID: 19610137 DOI: 10.3748/wjg.15.3367]
Corresponding Author of This Article
Ian Craig Lawrance, Professor, School of Medicine and Pharmacology, University of Western Australia, T Block, Fremantle Hospital, Alma Street, Fremantle, WA 6160, Australia. ian.lawrance@uwa.edu.au
Article-Type of This Article
Original Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 21, 2009; 15(27): 3367-3375 Published online Jul 21, 2009. doi: 10.3748/wjg.15.3367
Table 1 Grouping by MRI findings
Category 1
Category 2
Category 3
Category 4
Mucosal enhancement
Nil
Mild
Mild
Mild or marked
Transmural enhancement
Nil
Nil or mild
Nil or mild
Marked
Wall thickness (mm)
> 3
< 6
> 6
> 3
Table 2 Characteristics of the CD patients prior to the MRI examination
CD (n = 52)
Gender: male
38.5% (20/52)
Age at diagnosis (yr)
38.9 ± 16.0 (14-79)
A1 ≤ 16
11.5% (6/52)
A2 17-40
55.8% (29/52)
A3 > 40
32.7% (17/52)
Crohn’s disease
L1 Terminal ileum
78.8% (41/52)
L2 Colon
0% (0/52)
L3 Ileocolonic
19.2% (10/52)
L4 Upper GI
7.7% (4/52)
P Perianal
9.6% (5/52)
B1 Non-stricturing
Non-penetrating
75.0% (39/52)
B2 Stricturing
19.2% (10/52)
B3 Penetrating
5.8% (3/52)
Colectomy
11.5% (6/52)
Terminal ileal resection
25.0% (13/52)
Proximal SB resection
1.9% (1/52)
Table 3 MRI findings of patients according to the MRI category
MRI group (n)
Male (%)
Age (yr)
Bowel length involved (cm)
Wall thickness (mm)
Degree of SB wall enhancement
Mucosal enhancement (%)
Transmural enhancement (%)
Mesenterichyperaemia (%)
Fibrofatty proliferation (%)
Regional lymph nodes (%)
Free fluid (%)
Narrowed lumen no hold-up (%)
Prestenotic dilation ± holdup (%)
Fistula (%)
1 (7)
28.6
37.9 ± 9.4
6.3 ± 7.9
< 3 0%
None 100%
0
0
0
14.3
0
14.3
57.1
14.3
0
(23-54)
(1-25)
3-6 71.4%
Mild 0%
> 6 28.6%
Marked 0%
2 (9)
22.2
32.8 ± 9.2
13.8 ±12.3
< 3 11.1%
None 0%
100
88.9
33.3
33.3
66.6
33.3
44.4
0
22.2
(17-78)
(3-30)
3-6 88.9%
Mild 100%
> 6 0%
Marked 0%
3 (16)
43.8
40.1 ± 16.2
16.2 ± 12.0
< 3 0%
None 0%
93.8
43.8
50.0
62.5
37.5
18.8
18.8
62.5
25.0
(14-79)
(2-50)
3-6 0%
Mild 100%
> 6 100%
Marked 0%
4 (20)
45.0
41 ± 19.2
19.2 ± 11.6
< 3 0%
None 0%
100
90.0
75.0
75.0
85.0
35.0
35.0
35.0
20.0
(14-49)
(2-45)
3-6 10%
Mild 0%
> 6 90%
Marked 100%
Table 4 MRI category, medical therapy and clinical response (%)
MRI group
Steroids
5ASA
Antibiotics
AZA/6MP
MTX
Anti-TNF α
Response
1 (n = 7)
57.10
57.10
28.50
85.70
0.00
42.90
14.30
2 (n = 9)
55.50
88.90
0.00
22.20
33.30
44.40
100.00
3 (n = 16)
81.30
68.80
6.30
50.00
0.00
12.50
43.80
4 (n = 20)
70.00
70.00
5.00
40.00
0.00
35.00
50.00
Responders (n = 27)
63.00
63.00
11.10
44.40
3.70
25.90
N/A
Non-responders (n = 25)
76.00
80.00
4.00
48.00
8.00
36.00
N/A
Table 5 MRI category, response to medical therapy in relation to luminal narrowing with and without hold up
MRI group
No narrowed lumen
Narrowed lumen no hold up
Narrowed lumen with hold up
1
Response 0% (0/2)
Response 25% (1/4)
Response 0% (0/1)
n = 7
No response 100% (2/2)
No response 75% (3/4)
No response 100% (1/1)
2
Response 100% (5/5)
Response 100% (4/4)
Response N/A
n = 9
No response 0% (0/5)
No response 0% (0/4)
No response N/A
3
Response 66.7% (2/3)
Response 66.7% (2/3)
Response 40% (4/10)
n = 16
No response 33.3% (1/3)
No response 33.3% (1/3)
No response 60% (6/10)
4
Response 83.3% (5/6)
Response 57.1% (4/7)
Response 14.3% (1/7)
n = 20
No response 16.7% (1/6)
No response 42.9% (3/7)
No response 85.7% (6/7)
Total
Response 75.0% (12/16)
Response 61.1% (11/18)
Response 27.8% (5/18)
n = 52
No response 25.0% (4/16)
No response 38.9% (7/18)
No response 72.2% (7/18)
Table 6 Correlation of MRI findings with surgical pathology
No.
Sex
Age
MRI assessment
Surgical pathology
Group
Fistula
Inflammation
Fibrosis
Fistula
1
F
23
1
No
Minimal
Yes
No
2
M
45
1
No
No
Yes
No
3
F
39
2
Yes
Mild
No
Yes
4
M
17
3
No
Mild
Yes
No
5
F
59
3
No
Mild
Yes
No
6
F
31
3
No
Mild
Yes
No
7
M
18
3
No
Moderate
Yes
No
8
M
24
3
Yes
Mild
Yes
Yes
9
F
37
3
No
Mild
Yes
No
10
M
41
3
No
Mild
Yes
No
11
F
62
4
No
Florid
Yes
No
12
M
19
4
No
Florid
Yes
No
13
M
61
4
No
Florid
Yes
No
14
F
21
4
Yes
Florid
No
Yes
15
M
43
4
Yes
Florid
Yes
Yes
16
M
14
4
No
Florid
No
No
17
F
56
4
No
Florid
No
No
Citation: Lawrance IC, Welman CJ, Shipman P, Murray K. Correlation of MRI-determined small bowel Crohn’s disease categories with medical response and surgical pathology. World J Gastroenterol 2009; 15(27): 3367-3375